GSK plc reported on January 15, 2024, that various executives, including the CEO, increased their shareholdings through dividend reinvestment from dividends paid on January 11, 2024, totaling 2,327 shares at £15.5640 each in London and 596 American Depositary Shares at $39.6400 each in New York.